Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.


We welcome all correspondence from those interested in our company, products, and research.

Mailing Address
Nutra Pharma Corporation
12502 W. Atlantic Blvd
Coral Springs, FL 33071 USA

Office: (954) 509-0911
Fax: (877) 895-5647

Attention Shareholders
Due to SEC Regulation Fair Disclosure, we cannot communicate individually with shareholders. For answers to basic shareholder questions pertaining to the location of historical factual information contained within the Company’s past press releases and/or the Company’s website, you may email

Please note: We cannot address any questions pertaining to corporate financial information, including, but not limited to, past, present or future stock performance.

Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.


Recent News
September 09, 2015
Nutra Pharma To Present at Upcoming Investment Conference

September 08, 2015
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration for the Treatment of Juvenile Multiple Sclerosis

July 15, 2015
Nutra Pharma Announces the Submission of Their First Orphan Drug Application to the US Food and Drug Administration (FDA)

Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
Facebook   Twitter
Privacy Policy Code of Ethics